# Phase 1 liver cancer trials recruiting: 28 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 28 trials in phase 1 for liver cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 liver cancer trials: 28 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/liver-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 28
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 13, 2026 | NCT07763301 | YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies | West China Hospital | Phase 1 | Recruiting | Liver Cancer, Pancreatic Cancer, Biliary Tract Cancer (BTC) | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763301) |
| April 8, 2026 | NCT07517198 | Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | Phase 1 | Recruiting | Solid Tumor, Small Cell Lung Cancer (SCLC), High Grade Neuroendocrine Cancer, Small Cell Carcinomas of Non-lung Origin... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517198) |
| February 27, 2026 | NCT07436988 | Affordable Made-in-India Microspheres for Liver Cancer Therapy | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 1 | Not yet recruiting | Hepatecellular Carcinoma | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07436988) |
| February 24, 2026 | NCT07430202 | A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With... | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 | Recruiting | Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC)) | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07430202) |
| February 5, 2026 | NCT07390838 | A Study of SH009 Injection in Patients With Advanced Solid Tumors. | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Phase 1 | Recruiting | Liver Cancer (Locally Advanced or Metastatic), Lung Cancer (NSCLC), Head and Neck Cancer Squamous Cell Carcinoma... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390838) |
| January 13, 2026 | NCT07337525 | A First in Human Study of PLT012 in Participants With Solid Tumor Cancers | Pilatus Biosciences Inc | Phase 1 | Recruiting | Advanced Malignant Solid Tumor, Solid Tumor Cancer | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07337525) |
| January 5, 2026 | NCT07317505 | A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors | Conjupro Biotherapeutics, Inc. | Phase 1 | Recruiting | Cancer, Cancer (Solid Tumors) | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07317505) |
| November 4, 2025 | NCT07224568 | Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors | Seattle Children's Hospital | Phase 1 | Not yet recruiting | Solid Tumor (Excluding CNS), Hepatocellular Carcinoma, Liver Cell Carcinoma, Liposarcoma, Yolk Sac Tumor... | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224568) |
| August 29, 2025 | NCT07148050 | Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor... | Seattle Children's Hospital | Phase 1 | Recruiting | Solid Tumor (Excluding CNS), Liver Cell Carcinoma, Malignant Rhabdoid Tumor, Yolk Sac Tumor, Liposarcoma... | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07148050) |
| July 8, 2025 | NCT07053072 | PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma. | West China Hospital | Phase 1 | Recruiting | Liver Cancer | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07053072) |
| June 3, 2025 | NCT07001592 | Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Phase 1 | Recruiting | Gastric Neoplasms, Esophageal Cancer, Liver Cancer, Liver Metastasis, MSS-CRC, MSS, Gastric Adenocarcinoma, Peritoneal... | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07001592) |
| March 13, 2025 | NCT06873659 | SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | Qurgen Inc. | Phase 1 | Recruiting | Solid Tumor, Gastric Cancer, Liver Cancer | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06873659) |
| March 5, 2025 | NCT06858813 | A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With... | AbbVie | Phase 1 | Recruiting | Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06858813) |
| November 14, 2024 | NCT06689540 | Mts105 for Advanced Hepatocellular Carcinoma | Sponsor not shown (see the record) | Phase 1 | Recruiting | Liver Cancer, Adult, Metastatic Liver Cancers, HCC - Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC) | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06689540) |
| November 14, 2024 | NCT06687941 | A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors | Aptamer Sciences, Inc. | Phase 1 | Recruiting | Neoplasms, Carcinoma, Hepatocellular, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06687941) |
| November 4, 2024 | NCT06673329 | Brodalumab in the Treatment of Immune-Related Adverse Events | Sponsor not shown (see the record) | Phase 1 | Recruiting | Breast Cancer, Esophageal Cancer, Kidney Cancer, Lung Cancer, Thyroid Cancer, Gynecologic Cancer, Pancreatic Cancer... | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06673329) |
| September 19, 2024 | NCT06600321 | A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma | Alnylam Pharmaceuticals | Phase 1 | Recruiting | Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma | 158 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06600321) |
| August 1, 2024 | NCT06533332 | A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors | EtiraRx Australia Pty Ltd | Phase 1 | Recruiting | Advanced Solid Tumor, Metastatic Breast Cancer, Metastatic Ovarian Cancer, Metastatic Endometrial Cancer, Metastatic... | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06533332) |
| June 27, 2024 | NCT06478693 | A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC | Myeloid Therapeutics | Phase 1 | Recruiting | Hepatocellular Carcinoma | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06478693) |
| June 3, 2024 | NCT06440005 | A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors | Angiex, Inc. | Phase 1 | Recruiting | Cancer, Advanced Cancer, Locally Advanced Carcinoma, Metastatic Solid Tumor, Breast Cancer, Prostate Cancer, Colorectal... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06440005) |
| March 22, 2024 | NCT06326502 | A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma | Etnova Therapeutics Corp. | Phase 1 | Recruiting | Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma, Liver Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06326502) |
| January 9, 2024 | NCT06196294 | GPC3/Mesothelin-CAR-γδT Cells Against Cancers | Second Affiliated Hospital of Guangzhou Medical University | Phase 1 | Recruiting | Pancreas Cancer, Lung Cancer, Liver Cancer, Mesothelioma, CAR-T Cell Therapy, Solid Tumor, Adult | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06196294) |
| October 16, 2023 | NCT06084299 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer | Sponsor not shown (see the record) | Phase 1 | Recruiting | Liver Cancer | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06084299) |
| February 15, 2022 | NCT05240950 | Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases | Changhai Hospital | Phase 1 | Recruiting | Colorectal Cancer, Metastatic Liver Cancer | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05240950) |
| December 13, 2021 | NCT05155189 | A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma | Zhejiang University | Phase 1 | Recruiting | Hepatocellular Carcinoma | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05155189) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Second Affiliated Hospital of Guangzhou Medical University | 2 |
| Seattle Children's Hospital | 2 |
| West China Hospital | 2 |
| Pilatus Biosciences Inc | 1 |
| Myeloid Therapeutics | 1 |
| [Alnylam Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/alnylam-pharmaceuticals) | 1 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 1 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| [Nanjing Sanhome Pharmaceutical, Co., Ltd.](https://specstream.ai/data/clinical-trials/company/nanjing-sanhome-pharmaceutical-co-ltd) | 1 |
| Conjupro Biotherapeutics, Inc. | 1 |
| Angiex, Inc. | 1 |
| Baylor College of Medicine | 1 |
| Qurgen Inc. | 1 |
| Zhejiang University | 1 |
| Etnova Therapeutics Corp. | 1 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 1 |
| Changhai Hospital | 1 |
| Aptamer Sciences, Inc. | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| National Cancer Institute (NCI) | 1 |
| EtiraRx Australia Pty Ltd | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 13 |
| China | 11 |
| South Korea | 4 |
| Australia | 2 |
| Taiwan | 2 |
| Italy | 1 |
| Israel | 1 |
| Japan | 1 |
| Puerto Rico | 1 |
| Spain | 1 |
| India | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Carpenters in the United States](https://specstream.ai/data/businesses/carpenters/united-states)
- [Medical billing companies in the United States](https://specstream.ai/data/businesses/medical-billing-companies/united-states)
- [Acupuncture clinics in the United States](https://specstream.ai/data/businesses/acupuncture-clinics/united-states)
- [Gastropubs in the United States](https://specstream.ai/data/businesses/gastropubs/united-states)
- [Shared office spaces in the United States](https://specstream.ai/data/businesses/shared-office-spaces/united-states)
- [Computer hardware companies in the United States](https://specstream.ai/data/businesses/computer-hardware-companies/united-states)
